David Ross Camidge

Director of Thoracic Oncology, Joyce Zeff Chair in Lung Cancer Research, University of Colorado Cancer Center.

Dr. David Ross Camidge is the Director of Thoracic Oncology at the University of Colorado. His focus is on Thoracic Malignancies and Developmental Therapeutics (Phase 1 studies). In 2012, he was announced as the recipient of the 5th Bonnie J. Addario Lectureship as a “Luminary in the quest to eradicate lung cancer.” In 2013, Dr. Camidge became the first physician to receive the Hank Baskett Sr. Spirit Award, for which he was credited as being “one of the leading minds in lung cancer today.” In 2015, he became the inaugural recipient of the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado Cancer Center. Dr. Camidge is also the National Medical Director of the Academic Thoracic Oncology Medical Investigators Consortium and a member of the National Comprehensive Cancer Network Lung Cancer Committee.

Dr Camidge’s main areas of clinical and research interest are thoracic malignancies and developmental therapeutics. The discoveries he and the Colorado team have made have changed the standard of care for the treatment of lung cancer multiple times. He has authored over 250 academic publications, including in the Journal of Thoracic Oncology, Journal of Clinical Oncology, Lancet Oncology, and New England Journal of Medicine. He has presented his work at numerous national and international meetings.

Following a PhD in Molecular Biology at the Medical Research Council’s Laboratory of Molecular Biology at Cambridge University, UK, Dr Camidge completed his medical training at Oxford University, UK. He then became the first person to double train in Medical Oncology and Clinical Pharmacology in the UK, before joining the University of Colorado.